iVigee Services
iVigee » Introducing iVigee’s Agentic AI Pharmacovigilance Department

Introducing iVigee's Agentic AI Pharmacovigilance Department

September 28, 2026

 

For as long as pharmacovigilance has been outsourced, offshored or brought back in-house, one assumption has remained: higher quality comes at a higher cost. 

iVigee is challenging that assumption. 

Today, we are launching our AI in Pharmacovigilance consultancy: a service through which we co-build an agentic AI pharmacovigilance department with you. Designed to deliver higher-quality outcomes, faster and at lower cost, the system is already being deployed with a select group of pharmacovigilance teams. 

How our agentic AI pharmacovigilance department works 

Dr. Jan Petracek, our CEO, introduces the concept in the video above, and he is clear about what it is, and what it is not. 

The system is designed to handle everything your pharmacovigilance department needs. In time, the entire department could potentially run on a single NVIDIA supercomputer. But the machine itself is never the whole solution. What makes the system work is the people who oversee it. 

Everything we have built incorporates human gates, reflecting the human-in-command, human-on-the-loop and human-in-the-loop models described in CIOMS XIV. AI agents do the heavy lifting; qualified people make the decisions; and accountability remains firmly with your team. 

Why it’s a consultancy, not software 

That is why we do not sell this as software. There is no manual to learn and no one-size-fits-all version to implement. 

Instead, we co-build the system with you, around your company, your processes and your people. The result is a system designed to fit your environment and address your specific needs, rather than forcing your organization to adapt to a predefined product. 

What does this mean for your PV team? 

Your people will always be needed. What changes is the work they do. 

We help your team develop the skills to supervise the work produced by the AI agents, while also becoming the builders who develop, run and continuously improve the system. In Jan’s view, that means moving away from repetitive, routine work and towards work that is genuinely engaging. 

If you have been wondering what agentic AI could actually look like within a pharmacovigilance department, this is where it starts. 

See what your pharmacovigilance department could become:

  

By Gemma Dailly
Marketing Director
Gemma Dailly is Marketing Director at iVigee and a seasoned marketing professional with extensive experience across clinical research and healthcare technology. Having held senior marketing roles at CluePoints and AARDEX Group, she specialises in building high-growth brands, developing strategic marketing programmes, and turning complex industry challenges into compelling stories that resonate with customers and stakeholders alike.
CONTACT IVIGEE

Have a PV challenge or question?

Free, with no obligation. Our team reads every message and replies personally within 48 hours.
CONTACT IVIGEE

Have a PV challenge or question?

Free, with no obligation. Our team reads every message and replies personally within 48 hours.
FEATURED CONTENT

Keep reading

Expert insights on pharmacovigilance, from AI in PV and inspection readiness to regulatory intelligence and signal management.
Dr. Jan Petracek, CEO of iVigee, smiling at a desk beside the title “More Drugs, More Data, More Work: Why Pharmacovigilance’s Biggest Era Is Ahead of Us.”
Thought Leadership

More Drugs, More Data, More Work: Why Pharmacovigilance’s Biggest Era Is Ahead of Us.

AI is accelerating drug discovery, and every new medicine will need safety monitoring. Why PV’s biggest era is still ahead.

Dr. Jan Petracek, CEO of iVigee, smiling at a desk beside the title “More Drugs, More Data, More Work: Why Pharmacovigilance’s Biggest Era Is Ahead of Us.”
Thought Leadership

More Drugs, More Data, More Work: Why Pharmacovigilance’s Biggest Era Is Ahead of Us.

AI is accelerating drug discovery, and every new medicine will need safety monitoring. Why PV’s biggest era is still ahead.

FREE PV BRIEFING

The PV briefing trusted by drug safety professionals.

In Signal Watch, our weekly LinkedIn newsletter, our physician-led team breaks down the latest regulatory changes, shares expert commentary, and gives you the practical insight you need to stay compliant and confident.

Subscribe now to stay in the loop.

iVigee Services, a.s.

Hvezdova 1716/2b, 140 00 Prague 4, Czech Republic

iVigee USA LLC

1500 District Avenue, Burlington, MA, United States

[email protected]

Book a Consultation

Tell us a little about what you need and one of our experts will be in touch within 48 hours.

We look forward to discussing AI in pharmacovigilance with you in more detail.
Marketing Consent*